• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转基因小鼠雄激素受体基因中扩展三核苷酸重复序列的稳定性

Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice.

作者信息

Bingham P M, Scott M O, Wang S, McPhaul M J, Wilson E M, Garbern J Y, Merry D E, Fischbeck K H

机构信息

Division of Neurology, Children's Hospital of Philadelphia, Pennsylvania, USA.

出版信息

Nat Genet. 1995 Feb;9(2):191-6. doi: 10.1038/ng0295-191.

DOI:10.1038/ng0295-191
PMID:7719348
Abstract

The expansion of trinucleotide repeat sequences underlies a number of hereditary neurological disorders. To study the stability of a trinucleotide repeat and to develop an animal model of one of these disorders, spinal and bulbar muscular atrophy (SBMA), we have generated transgenic mice carrying either the normal or expanded repeat human androgen receptor (AR) gene. Unlike the disease allele in humans, the AR cDNA containing the expanded repeat in transgenic mice showed no change in repeat length with transmission. Expression of the SBMA AR was found in transgenic mice, but at a lower level than normal endogenous expression. The lack of a physiological pattern of expression may explain why no phenotypic effects of the transgene were observed.

摘要

三核苷酸重复序列的扩增是多种遗传性神经疾病的基础。为了研究三核苷酸重复序列的稳定性,并开发其中一种疾病——脊髓延髓肌萎缩症(SBMA)的动物模型,我们构建了携带正常或扩增重复序列的人类雄激素受体(AR)基因的转基因小鼠。与人类的疾病等位基因不同,转基因小鼠中含有扩增重复序列的AR cDNA在传递过程中重复长度没有变化。在转基因小鼠中发现了SBMA AR的表达,但水平低于正常内源性表达。缺乏生理性表达模式可能解释了为何未观察到转基因的表型效应。

相似文献

1
Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice.转基因小鼠雄激素受体基因中扩展三核苷酸重复序列的稳定性
Nat Genet. 1995 Feb;9(2):191-6. doi: 10.1038/ng0295-191.
2
Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.在X连锁性脊髓延髓肌肉萎缩症小鼠模型中,内源性雄激素受体蛋白的缺失加速了运动神经元变性,并加剧了雄激素不敏感性。
Hum Mol Genet. 2006 Jul 15;15(14):2225-38. doi: 10.1093/hmg/ddl148. Epub 2006 Jun 13.
3
Polymorphic CAG repeat length in the androgen receptor gene and association with neurodegeneration in a heterozygous female carrier of Kennedy's disease.肯尼迪病杂合子女性携带者中雄激素受体基因的多态性CAG重复长度及其与神经变性的关联。
J Neurol. 2004 Jan;251(1):35-41. doi: 10.1007/s00415-004-0266-x.
4
Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy.X连锁脊髓延髓肌肉萎缩症中三核苷酸重复序列的减数分裂稳定性及基因型-表型相关性
Nat Genet. 1992 Dec;2(4):301-4. doi: 10.1038/ng1292-301.
5
[Clinical manifestations and molecular genetics of spinal bulbar muscular atrophy: report of 5 cases].脊髓延髓肌肉萎缩症的临床表现及分子遗传学:5例报告
Zhonghua Yi Xue Za Zhi. 2007 Jun 19;87(23):1611-5.
6
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.17-AAG是一种热休克蛋白90(Hsp90)抑制剂,可改善多聚谷氨酰胺介导的运动神经元变性。
Nat Med. 2005 Oct;11(10):1088-95. doi: 10.1038/nm1298. Epub 2005 Sep 11.
7
[Animal models of neurodegenerative diseases on the road to disease-modifying therapy: spinal and bulbar muscular atrophy].
Rinsho Shinkeigaku. 2007 Nov;47(11):941-3.
8
[Molecular pathogenesis of motor neuron diseases].[运动神经元疾病的分子发病机制]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2001 Feb;21(1):21-25.
9
[Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].[X连锁性脊髓延髓肌萎缩症中雄激素受体表达与神经元易损性的研究]
Hokkaido Igaku Zasshi. 1996 Nov;71(6):785-99.
10
Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).脊髓延髓性肌萎缩症(SBMA)的转基因小鼠模型。
Cytogenet Genome Res. 2003;100(1-4):243-51. doi: 10.1159/000072860.

引用本文的文献

1
Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy.探索翻译后修饰在脊髓延髓肌萎缩症中的作用。
Front Mol Neurosci. 2022 Jun 3;15:931301. doi: 10.3389/fnmol.2022.931301. eCollection 2022.
2
What is the Pathogenic CAG Expansion Length in Huntington's Disease?亨廷顿病的致病 CAG 扩增长度是多少?
J Huntingtons Dis. 2021;10(1):175-202. doi: 10.3233/JHD-200445.
3
The Contribution of Somatic Expansion of the CAG Repeat to Symptomatic Development in Huntington's Disease: A Historical Perspective.
CAG 重复序列的体细胞扩增对亨廷顿病症状发展的贡献:历史视角。
J Huntingtons Dis. 2021;10(1):7-33. doi: 10.3233/JHD-200429.
4
Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer.三核苷酸重复扩增疾病、RNA干扰与癌症。
Trends Cancer. 2018 Oct;4(10):684-700. doi: 10.1016/j.trecan.2018.08.004. Epub 2018 Sep 26.
5
Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.脊髓延髓肌萎缩症的发病机制和治疗策略。
CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1146-56.
6
Mouse models of polyglutamine diseases: review and data table. Part I.多聚谷氨酰胺疾病的小鼠模型:综述和数据表。第一部分。
Mol Neurobiol. 2012 Oct;46(2):393-429. doi: 10.1007/s12035-012-8315-4. Epub 2012 Sep 7.
7
Prenatal flutamide enhances survival in a myogenic mouse model of spinal bulbar muscular atrophy.产前氟他胺增强肌源性脊髓延髓肌肉萎缩症小鼠模型的存活率。
Neurodegener Dis. 2011;8(1-2):25-34. doi: 10.1159/000313682. Epub 2010 Aug 4.
8
Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.脊髓延髓肌肉萎缩症肌源性小鼠模型中功能的恢复
Neurobiol Dis. 2009 Apr;34(1):113-20. doi: 10.1016/j.nbd.2008.12.009. Epub 2008 Dec 31.
9
Animal models of polyglutamine diseases and therapeutic approaches.多聚谷氨酰胺疾病的动物模型及治疗方法。
J Biol Chem. 2009 Mar 20;284(12):7431-5. doi: 10.1074/jbc.R800065200. Epub 2008 Oct 28.
10
Androgen receptor and Kennedy disease/spinal bulbar muscular atrophy.雄激素受体与肯尼迪病/脊髓延髓肌肉萎缩症
Horm Behav. 2008 May;53(5):729-40. doi: 10.1016/j.yhbeh.2007.12.009. Epub 2008 Jan 5.